Margaret Duffy PhD, CSO and Co-founder of Theolytics, shared, "I am excited to welcome David to the Team. His unique blend of experience across immune-oncology, infectious diseases and rare diseases ...
(ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is pleased to announce the filing of an Investigational New Drug ...